MiRNAs related to KRAS mutational status in resectable non-small cell lung cancer

被引：0

作者：

Gallach, S. ^{[1
]}

Calabuig-Farinas, S. ^{[1
]}

Jantus-Lewintre, E. ^{[1
]}

Montaner, D. ^{[2
]}

Escorihuela, E. ^{[1
]}

Castellano, J. ^{[1
]}

Figueroa, S. ^{[3
]}

Blasco, A. ^{[4
]}

Hernando, C. ^{[4
]}

Guijarro, R. ^{[5
]}

Camps, C. ^{[5
]}

机构：

[1] Fdn Invest Hosp Gen Valencia, Valencia, Spain

[2] Ctr Invest Principe Felipe, Dept Bioinformat, Valencia, Spain

[3] Consorcio Hosp Gen Univ Valencia, Serv Cirugia Torac, Valencia, Spain

[4] Consorcio Hosp Gen Univ Valencia, Serv Oncol Med, Valencia, Spain

[5] Univ Valencia, Dept Med, Valencia, Spain

来源：

EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷

关键词：

D O I：

10.1016/S0959-8049(14)70671-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

545

引用

页码：177 / 177

页数：1

共 50 条

[31] Mutational landscape with a focus on KRAS mutations in non-small lung cancer in Taiwan. [J].

Tran, Nguyet ;

Bonner, Joseph D. ;

Chen, Wei-Ju ;

Lin, Fang-Wei ;

Gruber, Peter J. ;

Lange, Jeff ;

Lauer, Andrea ;

Gruber, Stephen B. .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

[32] The Impact of Estrogen Receptor Expression on Mutational Status in the Evolution of Non-Small Cell Lung Cancer [J].

Tani, Yoko ;

Kaneda, Hiroyasu ;

Koh, Yasuhiro ;

Tamiya, Akihiro ;

Isa, Shunichi ;

Kubo, Akihito ;

Ogawa, Koichi ;

Matsumoto, Yoshiya ;

Sawa, Kenji ;

Yoshimoto, Naoki ;

Mitsuoka, Shigeki ;

Kawaguchi, Tomoya .

CLINICAL LUNG CANCER, 2023, 24 (02) :165-174

[33] Metastatic pattern in non-resectable non-small cell lung cancer [J].

Stenbygaard, LE ;

Sorensen, JB ;

Larsen, H ;

Dombernowsky, P .

ACTA ONCOLOGICA, 1999, 38 (08) :993-998

[34] Comparative analysis of three NGS platforms assessing tumor mutational burden and mutational landscape in resectable non-small cell lung cancer [J].

Lee, J. B. ;

Choi, S. J. ;

Kim, J. H. ;

Hong, M. H. ;

Cho, B. C. ;

Lim, S. M. .

ANNALS OF ONCOLOGY, 2023, 34 :S1649-S1649

[35] Can Unresectable Non-Small Cell Lung Cancer Become Resectable? [J].

Chaft, Jamie E. .

CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (06) :261-262

[36] Perioperative Systemic Therapy for Resectable Non-Small Cell Lung Cancer [J].

Muthusamy, Bharathi ;

Patil, Pradnya D. ;

Pennell, Nathan A. .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (08) :953-961

[37] Patterns of systemic chemotherapy in resectable non-small cell lung cancer [J].

Dubey, S. ;

Su, R. ;

Nalbandian, G. ;

Hwang, J. ;

Jahan, T. M. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

[38] Neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer [J].

Broderick, Stephen R. ;

Bott, Matthew J. .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 158 (05) :1471-1474

[39] Neoadjuvant immunotherapy in resectable non-small cell lung cancer at a checkpoint [J].

Faltermeier, Claire M. ;

Lee, Jay M. .

TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (12) :4328-4335

[40] Management of Patients With Resectable and Metastatic Non-Small Cell Lung Cancer [J].

Yanagawa, Jane ;

Riely, Gregory J. .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (5.5)

← 1 2 3 4 5 →